Exon Skipping in a Dysf-Missense Mutant Mouse Model
Limb girdle muscular dystrophy 2B (LGMD2B) is without treatment and caused by mutations in the dysferlin gene (DYSF). One-third is missense mutations leading to dysferlin aggregation and amyloid formation, in addition to defects in sarcolemmal repair and progressive muscle wasting. Dysferlin-null mo...
Saved in:
Main Authors: | Jakub Malcher (Author), Leonie Heidt (Author), Aurélie Goyenvalle (Author), Helena Escobar (Author), Andreas Marg (Author), Cyriaque Beley (Author), Rachid Benchaouir (Author), Michael Bader (Author), Simone Spuler (Author), Luis García (Author), Verena Schöwel (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2018-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of Novel Antisense-Mediated Exon Skipping Targets in DYSF for Therapeutic Treatment of Dysferlinopathy
by: Joshua J.A. Lee, et al.
Published: (2018) -
Histone deacetylase inhibitors improve antisense-mediated exon-skipping efficacy in mdx mice
by: Flavien Bizot, et al.
Published: (2022) -
Natural Exon Skipping Sets the Stage for Exon Skipping as Therapy for Dystrophic Epidermolysis Bullosa
by: Jeroen Bremer, et al.
Published: (2019) -
Non-small-cell lung cancer: how to manage MET exon 14 skipping mutant disease
by: Juan Bautista Blaquier, et al.
Published: (2022) -
Targeted Exon Skipping to Correct Exon Duplications in the Dystrophin Gene
by: Kane L Greer, et al.
Published: (2014)